Sec. 820.80: Acceptance Activities
The Device Industry’s Silent Problem
An FDAnews Webinar Read More
Tenth Annual Medical Device Quality Congress
From Risk Management to Postmarket Surveillance
Bethesda, MD Read More
Dietary Supplement GMP Inspectional Readiness:
A Comprehensive Road Map To 21 CFR 111
An FDAnews Virtual Conference Read More
More Events

Home > Conferences > Creating, Staffing and Managing an Inspection War Room Your First Line of Defense

Creating, Staffing and Managing an Inspection War Room
Your First Line of Defense

Thursday, Nov. 8, 2012

Held Oct. 30, 2012

We’ve all heard the basic “How to Prepare for an Inspection” presentation. And we’ve heard your cries of “more detailed presentations, more specifics” on how to manage inspections.

Order Today

Too often, firms slap together what is essentially the central nervous system of their inspections. There’s no forethought into the who, what, where, why and how behind every good inspection is a good war room.

Recently, during a drug company inspection, a heated argument broke out — in front of an FDA inspector — between two employees who disagreed on their own company procedures. Don’t let this happen to you.

If you can’t confidently answer the following questions, order your CD/Transcript of this popular webinar.

Who is going to be in your war room and how should you determine assigned roles and seniority?
Who is responsible for guiding the FDA around a site? FDA investigators hate the “hordes” that follow them.
What kinds of information should you provide — and what’s off limits to the FDA?
What is considered privileged material or trade secrets and can you back your position up?
If the FDA asks about the price of a product or what you pay for a good or service, are you going to respond?
Photos within your facility? Yes or no? Either response has serious implications.

Order now.

Meet Your Instructor

Dr. Darshan Kulkarni is the principal attorney at the Kulkarni Law Firm. He focuses on strategic regulatory and pharmaceutical counseling and has extensive experience handling the needs of international pharmaceutical, biopharmaceutical, and medical device companies and their service providers, including contract manufacturing organizations and contract research organizations. As corporate counsel for a reputable, international pharmaceutical holding company, Darshan provided corporate and regulatory legal advice to international pharmaceutical, biotech, and medical device companies. He has had experience in corporate quality control and has worked in varying legal and regulatory areas, including crafting responses to FDA 483s, FDA recalls, and negotiating with and for CROs and sponsors. Dr. Kulkarni has worked as a pharmacist for more than 10 years in multiple capacities, including hospitals, retail pharmacies, managed care, and has even participated as a clinician in clinical trials.

Order now!

Who Will Benefit?

Participants include everyone who is a key player in hosting FDA inspections, including:

Senior Management
Regulatory Affairs
QA/QC
Subject Matter Experts
Inside and Outside Counsel
Manufacturing Management/Supervision
Laboratory Management/Supervision

Phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600

Shopping Cart

Your shopping cart is empty

Resource Center

Tenth Annual Medical Device Quality Congress
From Risk Management to Postmarket Surveillance
Come for this valuable opportunity to hear FDA officials discuss regulatory plans and objectives — and ask questions you need answered; learn from device industry experts, consultants and other experts with actionable tips and strategies you can take straight back to the office; and network with other professionals who understand your challenges; share war stories and insights over a drink. Register Today. Read More
Conducting Bulletproof CAPA Investigations — ADVANCED
Understanding Advanced Critical Thinking Skills and Innovative Techniques to Improve the Quality of Investigations and Understanding the Root Cause
The FDA's new enforcement plan makes one thing clear: Developing a successful CAPA program has never been more important. But creating an FDA-proof CAPA isn’t easy. If only you could pick the brain of someone who is coping successfully with CAPA — the best and the brightest, an industry leader who has devised programs, procedures and solutions that have put companies out in front with the FDA. Well, you can. Register today. Read More
Surviving an FDA Inspection
The FDA’s cadre of freshly trained inspectors — many of whom come directly from industry — and increased focus on specialized inspections are making it harder than ever to predict the outcome of your next FDA inspection. Unless, of course, you have Surviving an FDA Inspection at your fingertips. If you could spend less than $400 to get your drug manufacturing facility fully prepared to face a tough inspection by the FDA, would you even hesitate? ... Of course not! Read More

Creating, Staffing and Managing an Inspection War Room Your First Line of Defense

Audio CD/Transcript - Nov. 8, 2012

Creating, Staffing and Managing an Inspection War Room
Your First Line of Defense